[Management of acute myocardial infarction with ST-segment elevation: Update 2013]
S Birkmeier1, H Thiele, R Dörr
1Klinik für Innere Medizin/Kardiologie, Universität Leipzig - Herzzentrum, Strümpellstr. 39, 04289, Leipzig, Deutschland.
Herz
|September 27, 2013
Summary
This article updates ST-segment elevation myocardial infarction (STEMI) management based on 2012 European guidelines. It details diagnosis, emphasizing cardiac biomarkers and symptoms, and preferred reperfusion strategies, including new antiplatelet agents.
Area of Science:
- Cardiology
- Internal Medicine
Context:
- Presents the 2012 European Society of Cardiology guidelines for ST-segment elevation myocardial infarction (STEMI) management.
- Highlights the updated universal definition of myocardial infarction, focusing on myocardial necrosis.
- Discusses diagnostic criteria including cardiac biomarkers, ischemia symptoms, and ECG changes.
Purpose:
- To provide an update on STEMI management strategies.
- To detail diagnostic criteria and recommended treatment protocols.
- To emphasize optimal reperfusion strategies and the role of STEMI networks.
Summary:
- Primary percutaneous coronary intervention is the preferred reperfusion strategy for STEMI.
- Newer antiplatelet agents like prasugrel and ticagrelor are recommended over clopidogrel.
- Guidelines emphasize timely diagnosis, reperfusion, and the establishment of STEMI networks.
Impact:
- Informs healthcare professionals about current best practices in STEMI care.
- Aims to improve patient outcomes through optimized diagnosis and treatment.
- Stresses the importance of coordinated care through STEMI networks and updated therapeutic options.
More Related Videos
Related Concept Videos
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:30Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
01:14Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
01:26Angina IV: Management
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...